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SUMMARY
Introduction: Since there is no data concerning local analgesic effi-
cacy of ropivacaine for lower third molar surgery, the aim of this double-
blind study was to compare local anaesthetic parameters and postoperative 
analgesic requirements after the use of ropivacaine and bupivacaine for the 
inferior alveolar nerve block.  
Materials and Method: 20 healthy patients were equally randomised 
into the ropivacaine (0.75%, 2 ml) or bupivacaine (0.5%, 2 ml) groups. The 
onset and duration of anaesthesia (the lower lip numbness and pinprick test) 
and intensity of anaesthesia (visual analogue and verbal rating scales) were 
determined. The postoperative pain reports and analgesic requirements were 
also recorded.
Results: There were no significant differences concerning parameters 
of the achieved anaesthesia. 2 patients in the bupivacaine group felt post-
operative pain without the need for pain medication.
Conclusion: Ropivacaine is suitable for achieving local anaesthesia in 
lower third molar surgery, especially when prolonged analgesia is desired.
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Introduction
Ropivacaine is an amide long-acting anaesthetic, 
which has been increasingly used for regional nerve 
blocks1,2 as well as for epidural anaesthesia3 because 
of its lower potential to induce cardiovascular and 
neural toxicity in comparison to bupivacaine4,5. Studies 
comparing ropivacaine 0.5% with bupivacaine 0.5% for 
brachial plexus block showed no clinical difference in 
onset or duration of sensory block after the injection of 
30 ml of the solution1. Long-lasting analgesia of 10 to 12 
hours was reported for both ropivacaine and bupivacaine 
used for peripheral nerve blocks1, although ropivacaine 
exerted a slightly less potent analgesic effect than 
bupivacaine when used for epidural anaesthesia6. Used for 
intraoral block anaesthesia, 0.75% ropivacaine exerted an 
effective local anaesthetic action, producing long duration 
of inferior alveolar nerve block in volunteers, without 
surgical procedure7. 
Since there are no data concerning local analgesic 
efficacy of ropivacaine used for inducing intraoral block 
anaesthesia in dental or oral surgical practice, the aim of 
this study was to ascertain the achieved local anaesthetic 
parameters and postoperative analgesic requirements when 
0.75% ropivacaine was used to induce the inferior alveolar 
nerve block for lower third molar surgery, and to compare 
them to the same parameters achieved with standard long-
acting local anaesthetic (0.5% bupivacaine), sometimes 
used in the aforementioned indication.
Material and Method
After approval of the Ethical Board at the Faculty 
of Dentistry, 20 healthy patients requiring lower third 
molar surgery were randomly selected, in a double-blind 
fashion, into 2 groups: (1) a group of 10 patients receiving 
2 ml of 0.75% ropivacaine for inferior alveolar nerve 
block; and (2) a group of 10 patients receiving 2 ml of 
0.5% bupivacaine. No significant differences in patient 
characteristics, concerning the gender, age, body weight or 
difficulty of surgery concerning duration and need for root 
section, were reported between the groups (Tab. 1).
The onset of anaesthesia was evaluated using the 
patient’s report of lower lip numbness and the pinprick test 
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performed immediately after the injection, and in 30 sec 
intervals, till the first sign of soft tissue anaesthesia of the 
lower lip were detected. The duration of anaesthesia was 
reported by the patient at the first control appointment. 
The response to visual analogue (VAS) and verbal rating 
scales (VRS), done immediately after surgery, determined 
the intensity of the achieved anaesthesia. The occurrence 
of postoperative pain and analgesic requirements were also 
recorded.
Table 1. Patient and Surgery Characteristics
Personal and 
Clinical Data
Groups
Ropivacaine 0.75% Bupivacaine 0.5%
N 10 10
M/F 4/6 5/5
Age / yr  (X ± SE) 23.2 ± 1.3 25.1 ± 2.4
Weight / kg  (X ± SE) 72.4 ± 1.6 69.2 ± 3.4
Duration  of surgery / 
min (X ± SE)
20.1 ± 2.4 18.3 ± 1.8
Impactions / 
partially impactions
3/7 4/6
Sections of molars 
(Yes / No)
4/6 5/5
Results 
The inferior alveolar nerve block was successfully 
achieved in all 20 patients. Differences in onset time 
between groups were small and statistically insignificant 
(Tab. 2). Both groups of patients demonstrated duration 
of the long-lasting range, although the duration of 
bupivacaine induced anaesthesia was slightly longer, but 
not significantly different (Tab. 2).
Intensity of the achieved anaesthesia after the intraoral 
block was similar in both groups, estimated clinically by 
visual analogue and verbal rating scales, and no additional 
anaesthesia was needed in any of the cases (Tab. 3).
Postoperative analgesia, leading to a reduced need 
for administration of postoperative analgesics, was of 
long-duration; only 2 patients in the bupivacaine group 
felt some postoperative pain, without the need for pain 
medication (Tab. 4).
Table 2. Onset and Duration of the Inferior Alveolar Nerve Block
Groups N
Onset/min    (X ± SE)
Duration/min
(X ± SE)
numbness pinprick numbness pinprick
Ropivacaine 10 7.3 ± 3.5 5.6 ± 2.3 582 ± 67 450 ± 73
Bupivacaine 10 8.7 ± 2.2 7.4 ± 1.4 688 ± 85 550 ± 48
Table 3. Intensity of the Inferior Alveolar Nerve Block
Method of measurement
Intensity
Ropivacaine Bupivacaine
V A S (mm) 12 ± 2 14 ± 3
V R S
no pain at all 7 5
just noticeable pain 3 4
weak pain 0 1
moderate pain 0 0
severe pain 0 0
excruciating pain 0 0
Total number 10 10
Table 4. Postoperative analgesia
Parameters
Groups
Ropivacaine Bupivacaine
Postoperative pain 
(No. of patients)
0 2
Need for pain medication
No. of ibuprofen doses (400 mg)
0 0
Discussion
Ropivacaine 0.75% exerted good local anaesthetic 
properties to fulfil demands for painless oral surgery 
in the mandible, comparable with those obtained with 
bupivacaine. Differences in onset time between the 
groups were small which could be considered as clinically 
insignificant, because all the values were below the usual 
ones accepted for the onset of local anaesthesia achieved 
by long-acting local anaesthetics. A small reduction in the 
onset time noted after the inferior alveolar nerve block 
with ropivacaine could possibly be the result of the use of 
a higher concentration of the solution when compared to 
bupivacaine. Similarly, it was also reported that the onset 
of sensory block was shorter in the ropivacaine group than 
in the bupivacaine for cervical plexus block, again without 
significant clinical difference2.
Concerning duration of the achieved inferior alveolar 
nerve block, both groups of patients demonstrated 
duration of the long-lasting range, although the duration 
of bupivacaine induced anaesthesia was slightly longer, 
but not significantly different. The slight difference in 
length of sensory anaesthesia following nerve blocks has 
also been reported when identical doses of ropivacaine 
and bupivacaine were applied for spinal8, as well as for 
brachial plexus bock9. It was suggested that the shorter 
duration of anaesthesia achieved with ropivacaine, 
compared to that of bupivacaine, could be the result of 
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lesser lipid solubility of ropivacaine10 and consequent 
lesser absorption by nerve tissue after local application.
The intensity of the achieved local anaesthesia is 
probably one of the most important concerns in dentistry. 
Probably due to the relatively shorter duration of 
anaesthesia, previous studies have established ropivacaine 
as a slightly less potent local anaesthetic compared 
with bupivacaine6. Our study, however, pointed to a 
similar intensity of the achieved anaesthesia after the 
intraoral block in both groups, estimated clinically by 
visual analogue and verbal rating scales. Profound block 
anaesthesia in the ropivacaine group, without any pain 
during surgery, was achieved in 70% of patients, which 
was even slightly higher than in the bupivacaine group. 
However, probably the most important result was that no 
additional anaesthesia was needed in any of the cases. 
Some favourable effects of ropivacaine, noticed in this 
clinical investigation, could be attributed to the slightly 
higher concentration of ropivacaine than bupivacaine 
used in the study and, additionally, by the already noticed 
vasoconstrictive properties of ropivacaine that interfere 
with the vascular resorption of the local anaesthetic11,12, 
which is probably of special importance in intraoral use of 
this solution.
An advantage of using long-duration local anaesthetics 
in dentistry, especially oral surgery, is their longer 
postoperative analgesia, which leads to a reduced need 
for the administration of postoperative analgesic drugs. In 
this investigation, only 2 patients in the bupivacaine group 
experienced some pain postoperatively. If we have in 
mind that the duration of sensory block was longer in the 
bupivacaine group, and that both anaesthetics used in this 
study satisfied requests of postoperative pain control, we 
would possibly need a larger group of patients and further 
research to clarify the possible analgesic superiority of 
ropivacaine over bupivacaine when used in oral surgery.
On the basis of these preliminary results of this 
clinical study, ropivacaine seems to be suitable for 
achieving inferior alveolar nerve block during lower 
third molar surgery, exerting satisfactory intensity of 
local anaesthesia and prominent postoperative analgesic 
potency, similar to that of bupivacaine. Accordingly, 
ropivacaine could be recommended for use in oral surgery 
when a long-acting anaesthetic is indicated. Moreover, 
its faster onset and recovery of sensory block, as well as 
lowered cardio-toxicity5, could be an attractive advantage 
over bupivacaine. However, further studies are needed to 
verify these favours.
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